STEPHEN P. CAREY - 12 Aug 2025 Form 4 Insider Report for ANI PHARMACEUTICALS INC (ANIP)

Role
SVP & CFO
Signature
/s/ Stephen P. Carey, by attorney-in-fact Meredith W. Cook
Issuer symbol
ANIP
Transactions as of
12 Aug 2025
Net transactions value
-$4,303,500
Form type
4
Filing time
14 Aug 2025, 17:40:55 UTC
Previous filing
25 Mar 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
CAREY STEPHEN P. SVP & CFO C/O ANI PHARMACEUTICALS, INC., 210 MAIN STREET WEST, BAUDETTE /s/ Stephen P. Carey, by attorney-in-fact Meredith W. Cook 14 Aug 2025 0001674236

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIP Common Stock Options Exercise $2,324,500 +50,000 +28% $46.49 230,863 12 Aug 2025 Direct
transaction ANIP Common Stock Sale $4,303,500 -50,000 -22% $86.07 180,863 12 Aug 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANIP Stock Option (right to buy) Options Exercise $2,324,500 -50,000 -100% $46.49 0 12 Aug 2025 Common Stock 50,000 $46.49 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the total options vested on each of May 6, 2017, May 6, 2018, May 6, 2019, and May 6, 2020.